Severe Combined Immunodeficiency: A Case Series and Review from a Tertiary Pediatric Hospital
-
Shahrzad Fallah
,
Mehrnaz Mesdaghi
,
Mahboubeh Mansouri
,
Delara Babaei
,
Abdollah Karimi
,
Seyed Alireza Fahimzad
,
Shahnaz Armin
,
Sedigheh Rafiei Tabatabaei
,
Roxana Azma
,
Ghamartaj Khanbabaee
,
Bahram Bashardoost
,
Mehrdad Amirmoeini
,
Saeed Sadr
,
Rozita Jalilianhasanpour
,
Roxana Ghanaei
,
Nima Rezaei
,
Zahra Chavoshzadeh
Abstract
Severe combined immunodeficiency syndrome (SCID) is a life-threatening condition leading to early infant death as a result of severe infection, due to impaired cellular and humoral immune systems. Various forms of SCID are classified based on the presence or absence of T cells, B cells and natural killer cells. Patients usually present with recurrent infections and failure to thrive. Definitive treatment is hematopoietic stem cell transplantation. To achieve the best outcome, it should be performed prior to the development of severe infection. In This study, we described 10 patients (6 male and 4 female) with SCID who were admitted to Mofid Children Hospital, Tehran, Iran, from 2006 to 2013. We reviewed patients’ clinical manifestation, laboratory data, family history and outcome. The mean age at the time of diagnosis was 131.8 days. One patient had non-consanguineous parents. Seven patients received BCG vaccine before the diagnosis of SCID, three of them showed disseminated BCG infection. One patient presented with invasive pulmonary aspergillosis. Flow cytometric analysis showed T⁻B⁺NK⁻ in three patients, T⁻B⁻NK⁺ in five patients, T⁻B⁻NK⁻ in one patient, and T⁻B⁺NK⁺ in one patient. This study highlights the importance of early diagnosis and patient referral before the occurrence of serious infection.
1. Yeganeh M, Heidarzade M, Pourpak Z, Parvaneh N, Rezaei N, Gharagozlou M, et al. Severe combined immunodeficiency: A cohort of 40 patients. Pediatr Allergy Immunol 2008; 19(4):303-6.
2. Buckley RH. Molecular defects in human severe combined immunodeficiency and approaches toimmune reconstitution. Annu Rev Immunol 2004; 22:625-55.
3. Reust C E. Evaluation of primary immunodeficiency disease in children. Am Fam Physician 2013; 87(11):773-8.
4. Buckley RH. Advances in the understanding and treatment of human severe combined immunodeficiency. Immunol Res. 2000; 22(2-3):237-51.
5. Kelly BT, Tam JS, Verbsky JW, Routes JM. Screening for severe combined immunodeficiency in neonates. Clin Epidemiol 2013;5:363-9.
6. Saleem AF, Khawaja RDA, Shaikh AS, Ali SA, Zaidi AK. Severe combined immune deficiency syndrome. J Coll Physicians Surg Pak 2013; 23(8):570-3.
7. Conley ME, Notarangelo LD, Etzioni A. Diagnosticcriteriafor primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies).Clin Immunol 1999; 93(3):190-7.
8. Aghamohammadi A, Moein M, Farhoudi A, Pourpak Z, Rezaei N, AbolmaaliK, et al. Primary immunodeficiency in Iran: first report of the National Registry of PID in Children and Adults. J Clin Immunol 2002; 22(6):375-80.
9. Aghamohammadi A, Mohammadinejad P, Abolhassani H, Mirminachi B, Movahedi M, Gharagozlou M , et al. Primary Immunodeficiency Disorders in Iran: Update and New Insights from the Third Report of the National Registry. J Clin Immunol2014; 34(4):478-90.
10. FloríNM, Llambi MJ, Boren TE, Borja SR, Casariego GF. Primary Immunodeficiency Syndrome in Spain: First Report of the National Registry in Children and Adults. J Clin Immunol 1997; 17(4):333-9.
11. Boyle JM, Buckley RH. Population Prevalence of Diagnosed Primary Immunodeficiency Diseases in the United States. J Clin Immunol 2007; 27(5):497-502.
12. Stephan JL, Vlekova V, Deist FL, Blanche S, Donadieu J, De Saint-BasileG, et al. Severe combined immunodeficiency: A retrospective single-center study of clinical presentation and outcome in 117 patients. J Pediatr 1993; 123(4):564-72.
13. Buckley RH, Schiff RI, Schiffsh E, MarkertML, WilliamsLW, Harville TO, et al. Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. J Pediatr 1997; 130(3):378-87.
14. Nofech-Mozes Y, Blaser SI, Kobayashi J, Grunebaum E, Roifman CM. Neurologic abnormalities in patients with adenosine deaminase deficiency. Pediatr Neurol 2007; 37(3):218-21.
15. Roxo-Junior P, Silva J, Andrea M, Oliveira L, Ramalho F, Bezerra T. A family history of serious complications due to BCG vaccination is a tool for the early diagnosis of severe primary immunodeficiency. Ital J Pediatr 2013; 39:54.
16. Norouzi S, Aghamohammadi A, Mamishi S, Rosenzweig SD, Rezaei N. Bacillus Calmette-Guérin (BCG) complications associated with primary immunodeficiency diseases. J Infect 2012; 64(6):543-54.
17. Afshar Paiman S, Siadati A, Mamishi S, Tabatabaie P, Khotaee G. Disseminated Mycobacterium bovis infection after BCG vaccination. Iran J Allergy Asthma Immunol 2006; 5(3):133-7.
18. Sadeghi-Shabestari M, Rezaei N. Disseminated bacilleCalmette-Guérin in Iranian children with severe combined immunodeficiency. Int J Infect Dis 2009; 13(6):e420-e423.
19. Moin A, Farhoudi A, Moin M, PourpakZ, Bazargan N. Cutaneous Manifestations of Primary Immunodeficiency Diseases in Children. Iran J Allergy Asthma Immunol 2006; 5(3):121-6.
20. Al-Herz W, Nanda A. Skin manifestations in primary immunodeficient children. PediatrDermatol 2011; 28(5):494-501.
21. Shahmohammadi S, Saffar MJ, Rezaei MS. BCG-osis after BCG vaccination in immunocompromised children: Case series and review. J Pediatr Rev2014; 2(1):47-54.
22. Antaya RJ, Gardner ES, Bettencourt MS, Daines M, Denise Y, Uthaisangsook S. Cutaneous complications of BCG vaccination in infants with immune disorders: two cases and a review of the literature. Pediatr Dermatol 2001; 18(3):205-9.
23. Gantzer A, Neven B, Picard C, Brousse N, Lortholary O, Fischer A, et al. Severe cutaneous bacillus Calmette–Guérin infection in immunocompromised children: the relevance of skin biopsy. J Cutan Pathol 2013; 40(1):30-7.
24. Tragiannidis A, Roilides E, Walsh TJ, Groll AH. Invasive Aspergillosis in Children with Acquired Immunodeficiencies. Clin Infect Dis 2012; 54(2):258-67.
25. Saito S, Oda A, Kasai M, Minami K, NagumoH, Shiohara M. A neonatal case of chronic granulomatous disease, initially presented with pulmonary aspergillosis in vasive. J Infect Chemother 2014; 20(3):220-3.
| Files | ||
| Issue | Vol 17, No 2 (2018) | |
| Section | Case Series | |
| Keywords | ||
| Neonatal screening Primary immunodeficiency disorder Severe combined immunodeficiency | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
